garcinol and Cirrhosis

garcinol has been researched along with Cirrhosis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Lawrence, L; Majeed, M; Majeed, S; Mundkur, L; Nagabhushanam, K	1
Chung, S; Kim, HS; Kim, M; Kim, S; Koh, ES; Park, CW; Shin, SJ; Son, M	1

Other Studies

2 other study(ies) available for garcinol and Cirrhosis

Article	Year
Novel Combinatorial Regimen of Garcinol and Curcuminoids for Non-alcoholic Steatohepatitis (NASH) in Mice. Scientific reports, 2020, 05-04, Volume: 10, Issue:1 Topics: Actins; Animals; Antioxidants; Diarylheptanoids; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Fatty Liver; Female; Fibrosis; Glutathione; Hep G2 Cells; Hepatic Stellate Cells; Humans; Inflammation; Liver; Liver Cirrhosis; Malondialdehyde; Mice; Mice, Inbred C57BL; Muscle, Smooth; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Superoxide Dismutase; Terpenes; Triglycerides	2020
Inhibition of p300/CBP-Associated Factor Attenuates Renal Tubulointerstitial Fibrosis through Modulation of NF-kB and Nrf2. International journal of molecular sciences, 2019, Mar-28, Volume: 20, Issue:7 Topics: Animals; Anti-Inflammatory Agents; Fibrosis; Inflammation; Kidney; Kidney Diseases; Male; Mice, Inbred C57BL; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; p300-CBP Transcription Factors; Terpenes	2019

Article

Year

Novel Combinatorial Regimen of Garcinol and Curcuminoids for Non-alcoholic Steatohepatitis (NASH) in Mice.

Scientific reports, 2020, 05-04, Volume: 10, Issue:1

Topics: Actins; Animals; Antioxidants; Diarylheptanoids; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Fatty Liver; Female; Fibrosis; Glutathione; Hep G2 Cells; Hepatic Stellate Cells; Humans; Inflammation; Liver; Liver Cirrhosis; Malondialdehyde; Mice; Mice, Inbred C57BL; Muscle, Smooth; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Superoxide Dismutase; Terpenes; Triglycerides

2020

Inhibition of p300/CBP-Associated Factor Attenuates Renal Tubulointerstitial Fibrosis through Modulation of NF-kB and Nrf2.

International journal of molecular sciences, 2019, Mar-28, Volume: 20, Issue:7

Topics: Animals; Anti-Inflammatory Agents; Fibrosis; Inflammation; Kidney; Kidney Diseases; Male; Mice, Inbred C57BL; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; p300-CBP Transcription Factors; Terpenes

2019